Connect with us


AmeriHealth New Jersey Offers Health Plans on the Federal Marketplace for the Sixth Consecutive Year


Beginning today New Jersey residents can choose from 10 different AmeriHealth New Jersey health plans across the bronze, silver and gold metallic levels on the federal marketplace.

On average, AmeriHealth New Jersey members will see a 14 percent decrease in premiums for 2019 before tax credits are applied to the premium.. This is in part due to the recent New Jersey-specific legislation signed by Governor Murphy, including the individual mandate and the reinsurance program. New Jersey is one of only two states nationally that will have an individual mandate in place.

With so much uncertainty surrounding health care reform, we are very pleased to reduce the cost of health insurance for our members in 2019, said Mike Munoz, market president for AmeriHealth New Jersey. We understand that everyone has competing financial pressures and health care is another expense to add to the list, but the health care system can only work properly if everyone participates. Whether this is your first time purchasing individual coverage, or if you are a returning customer, our team is ready to help.

Licensed sales agents are available by phone and can be reached at 1-888-879-5331. Residents can also visit  to find the health care coverage that is right for them. The website includes a subsidy estimator that allows individuals to quickly determine if they qualify for financial assistance and how much it will cover for 2019.

New Jersey residents also have the option of purchasing a plan directly from AmeriHealth New Jersey, which offers some cost-saving alternatives. There are 13 plans available off exchange, including three plans in the Select Suite that provide a 10 percent savings compared to their similar on-exchange counterparts. Off-exchange health plans are not subsidy eligible.

Regardless of whether health care coverage is purchased on or off the individual marketplace, individuals are encouraged to make health plan selections by November 30, 2018 to ensure ID card delivery by January 1, 2019.

Important dates to remember:

November 30 The recommended date for individuals to enroll in an AmeriHealth New Jersey health plan to ensure their January invoice reflects their new plan and that they receive their 2019 ID cards by January 1, 2019.
December 15 The last day to enroll in a health plan for 2019.

January 1, 2019

The first day new health care coverage begins.

This is the sixth consecutive year AmeriHealth New Jersey has participated in the federal marketplace. Despite the exit of other insurers over the years, we have remained committed to our community and the individual market, said Munoz. This year we are also expanding our efforts to provide Hispanic residents assistance with enrolling in individual health insurance plans.

AmeriHealth New Jersey will have Spanish-speaking licensed agents available to answer questions and enroll eligible individuals at local events throughout open enrollment.

Open enrollment runs today through Saturday, December 15. For more information on health plans available from AmeriHealth New Jersey visit

About AmeriHealth New Jersey

For nearly 25 years AmeriHealth New Jersey* has been dedicated to enhancing the health and well-being of the people and communities we serve. Our members are at the center of everything we do. Since the onset of the Affordable Care Act, we have been committed to offering health plans on the Individual Marketplace, which has expanded access to coverage for New Jersey residents. We are exclusively focused on New Jersey with plans designed to meet the unique needs of individuals, small- and mid-sized businesses, municipalities and boards of education across the state. We also provide administrative services to self-funded groups. Named one of the Best Places to Work for the past seven years, AmeriHealth New Jersey is located in Cranbury, NJ. For more information visit

*AmeriHealth Insurance Company of New Jersey | AmeriHealth HMO, Inc.

AmeriHealth New Jersey
Jill Roman, 609-662-2454
Public Relations
[email protected]


ROSEN, A TOP RANKED FIRM, Reminds Aurora Cannabis Inc. Investors of Important December 1 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ACB


NEW YORK, Nov. 24, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Aurora had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and inventory; (2) Aurora's purported “business transformation plan” and cost reset failed to mitigate the foregoing issues; (3) accordingly, it was foreseeable that Aurora would record significant goodwill and asset impairment charges; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 1, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].


Follow us for updates on LinkedIn:, on Twitter: or on Facebook:

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm's attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]


Cision View original content to download multimedia:–acb-301180155.html

SOURCE Rosen Law Firm, P.A.

Continue Reading


InMed Announces Election of Directors


VANCOUVER, BC, Nov. 24, 2020 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today confirmed that, at its annual general and special meeting of shareholders held on November 20, 2020 (the “Meeting”), all of the matters put forward before shareholders for consideration and approval as set out in InMed's notice of meeting and management information circular, dated October 7, 2020, were approved by the shareholders. In particular, shareholders approved the election of all director nominees to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. Results of the vote for the election of directors at the Meeting are set out as follows:


Votes For

Withheld Votes





Eric A. Adams





Adam Cutler





William J. Garner





Andrew Hull





Catherine Sazdanoff





InMed filed a report of voting results on SEDAR at on November 24, 2020.

About InMed: InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. For more information, visit

Cautionary Note Regarding Forward-Looking Information:

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities laws. Forward-looking information is based on management's current expectations and beliefs and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking information in this news release includes statements about: leading the way in the clinical development of CBN; developing a pipeline of cannabinoid-based medications in diseases with high unmet medical need; and delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines.

All forward-looking information herein is qualified in its entirety by this cautionary statement, and InMed disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.


Cision View original content:

SOURCE InMed Pharmaceuticals Inc.

Continue Reading


Glow Joins Nielsen Connect Partner Network to Accelerate Access to Consumer Insights


New partnership combines speed of Glow's research tech with Nielsen's industry-leading data to create greater value for researchers

MELBOURNE, Australia, Nov. 25, 2020 /PRNewswire/ — Today, it was announced that Glow, a leading tech platform in global consumer analytics, has joined the Nielsen Connect Partner Network, the data industry's largest open ecosystem of technology-driven solution providers for researchers, corporations and governments.

The new relationship enables Glow's real-time insights platform to support Nielsen's clients around the world. The partnership strengthens Glow as a leading provider of data analytics solutions and the alliance enables an expanded reach for Glow's innovative consumer insights platform.

“The Glow platform was built to supply businesses with real-time consumer data to bring certainty to decision making,” said Tim Clover, Founder and CEO of Glow.

“This new partnership means our online panel of 62 million people, across 45 countries, can be accessed by Nielsen's clients to garner rapid consumer sentiment, which is a valuable tool in the swiftly changing business environments we find ourselves in today.”

Brett Jones, Global Leader, Nielsen Connect Partner Network, said: “The Nielsen Connect Partner Network was formed to enable ongoing innovation, and we are thrilled to add Glow to our growing list of advanced data solution providers. We are excited about Glow's ability to help clients identify consumer trends and intentions in a rapid, nimble way.”

Since launching in 2016, the Nielsen Connect Partner Network has been instrumental in driving business value for more than 175 unique Nielsen clients by simplifying industry collaboration and providing more relevant and accurate results from partners that align to the way clients measure their business.

The Nielsen Connect Partner Network serves both partners and clients by making it easier for collaboration. With barriers removed, clients and partners transition their workload from managing data, to doing things with the data, all within the largest curated network of vendors available.

Existing Nielsen clients can book a Glow demo directly, here.

About Glow: Glow is a data research and analytics firm founded 7 years ago with the central goal of delivering rapid response insights to enable nimble decision making. Glow has made headway in the democratisation of research via a cloud-based platform which empowers business to understand, measure and extract quick turnaround public insights to support evolving organisational needs and objectives.

Glow delivers a specialised customer insights ecosystem, with easy-to-use tools and resources to inform a deep understanding of consumer and client sentiment. Its cost-effective, speed to insights capabilities means Glow is rapidly becoming a leading global research platform used by corporations and SMEs.

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News6 mins ago

GameIQ Spins Up Executive Team and Board of Directors

SAN DIEGO, Nov. 24, 2020 /PRNewswire-PRWeb/ — GameIQ, Inc., the creator and developer of the Spindy app, today announced new...

gbafNews28 gbafNews28
News6 mins ago

Option3Ventures Technology Board Member, Greg Akers, Appointed as Chief Technology Officer of Veracity Industrial Networks

NEW YORK, Nov. 24, 2020 /PRNewswire-PRWeb/ — Option3Ventures (O3V), a leading cybersecurity investment specialist firm, announced today that Greg Akers,...

gbafNews28 gbafNews28
News6 mins ago

Freedonia Analyst Weighs In On West Fraser's Acquisition of Norbord

CLEVELAND, Nov. 24, 2020 /PRNewswire/ — West Fraser Timber Company, a leading supplier of lumber and other wood products extensively...

gbafNews28 gbafNews28
News6 mins ago

8 Ways to Protect Yourself Against Scams on Black Friday and Cyber Monday

SCOTTSDALE, Ariz., Nov. 24, 2020 /PRNewswire-PRWeb/ — The holidays are the most wonderful time of the year, especially for scammers....

gbafNews28 gbafNews28
News6 mins ago

Market America | SHOP.COM Partners With Packsize To Solve Packaging Constraints And Improve Efficiencies While Becoming More Environmentally Friendly

GREENSBORO, N.C., Nov. 24, 2020 /PRNewswire-PRWeb/ — Market America | SHOP.COM, a global product brokerage and internet marketing company that...

gbafNews28 gbafNews28
News6 mins ago

Glow Joins Nielsen Connect Partner Network to Accelerate Access to Consumer Insights

New partnership combines speed of Glow's research tech with Nielsen's industry-leading data to create greater value for researchers MELBOURNE, Australia,...

gbafNews28 gbafNews28
News6 mins ago

InMed Announces Election of Directors

VANCOUVER, BC, Nov. 24, 2020 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company...

gbafNews28 gbafNews28
News6 mins ago

ROSEN, A TOP RANKED FIRM, Reminds Aurora Cannabis Inc. Investors of Important December 1 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ACB

NEW YORK, Nov. 24, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities...

gbafNews28 gbafNews28
News8 mins ago

Fireblocks Raises $30 Million In Series B Funding Led by Paradigm

Fred Ehrsam joins Fireblocks Board of Directors as company looks to aggressively expand its presence in key global markets  ...

gbafNews28 gbafNews28
News8 mins ago

Allianz: Cyber crime brings expensive losses for companies, but internal failures most frequent cause of cyber claims

AGCS analysis of more than 1,700 cyber claims: External events such as “DDoS” attacks result in the most costly cyber...